PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Max von Pettenkofer Institute and Gene Center, Virology, National Reference Center for Retroviruses, Faculty of Medicine, LMU München, Munich, Germany.\', \'German Centre for Infection Research (DZIF), Partner Site, Munich, Germany.\', \'Institute of Molecular Immunology and Experimental Oncology, University Hospital rechts der Isar, Technical University of Munich (TUM), School of Medicine, Munich, Germany.\', \'Institute of Virology, Helmholtz Center Munich, TUM, School of Medicine, Munich, Germany.\', \'Pediatric Rheumatology / Special Immunology, Pediatrics Department, University Hospital Würzburg, Würzburg, Germany.\', \'Gene Center and Department of Biochemistry, LMU München, Munich, Germany.\', \'Laboratory for Functional Genome Analysis, Gene Center, LMU München, Munich, Germany.\', \'Bavarian Health and Food Safety Authority (LGL), Oberschleißheim, Germany.\', \'Institute of Clinical and Molecular Virology, University Hospital Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany.\', \'German Centre for Infection Research (DZIF), Partner Site, Munich, Germany. percy.knolle@tum.de.\', \'Institute of Molecular Immunology and Experimental Oncology, University Hospital rechts der Isar, Technical University of Munich (TUM), School of Medicine, Munich, Germany. percy.knolle@tum.de.\', \'Max von Pettenkofer Institute and Gene Center, Virology, National Reference Center for Retroviruses, Faculty of Medicine, LMU München, Munich, Germany. Keppler@mvp.uni-muenchen.de.\', \'German Centre for Infection Research (DZIF), Partner Site, Munich, Germany. Keppler@mvp.uni-muenchen.de.\', \'Gene Center and Department of Biochemistry, LMU München, Munich, Germany. Keppler@mvp.uni-muenchen.de.\', \'German Centre for Infection Research (DZIF), Partner Site, Munich, Germany. protzer@tum.de.\', \'Institute of Virology, Helmholtz Center Munich, TUM, School of Medicine, Munich, Germany. protzer@tum.de.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41591-022-01715-4
?:hasPublicationType
?:journal
  • Nature medicine
is ?:pmid of
?:pmid
?:pmid
  • 35090165
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 17.067
?:rankingScore_hIndex
  • 484
?:title
  • Three exposures to the spike protein of SARS-CoV-2 by either infection or vaccination elicit superior neutralizing immunity to all variants of concern.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all